WHG is a Health Policy Consulting & Government Relations Firm Based in Washington D.C. on Pennsylvania Ave. Between the Capitol & the White House
WHG Helps Clients Develop & Execute Successful Health Policy & Government Relations Strategies to Maximize Enterprise Value – COVID-19 New Era & Beyond
Wells Health Group Areas of Expertise
Why Choose WHG - Innovators in Health Policy & Government Relations
WHG's innovative approach to health policy consulting and government relations is built on a two-step sequential process founded on 70+ years successful healthcare industry and government relations experience:
Post Pandemic New Era and Beyond - Federal Agencies, Congress and the Administration require more and more decision-making to be made based upon clinical data and scientific evidence.
|
WHG's two-step process remains the successful foundation of our innovative approach to health policy consulting and government relations - clinical data evidence. Our proven processes helps us collaborate with clients to more effectively navigate all the new emergency use federal regulations.
Why Our 70+ Years Industry & Government Relations Experience Matters
- Because we come from the healthcare industry - WHG is uniquely positioned to best understand our client’s challenges and develop targeted government relations strategies.
- Because of our government relations experience representing industry, we knew it was critical for WHG to have a Washington D.C. presence.
- Because WHG is strategically located on Pennsylvania Avenue between the Capitol and the White House and just six blocks from the main HHS building, WHG has been able to more readily access face-to-face meetings at multiple levels of the HHS Agencies and on Capitol Hill.
- Because of WHG's previous years of Washington D.C. presence, participating in face-to-face meetings at multiple levels of the HHS Agencies and on Capitol Hill, we know how to leverage virtual access to multiple levels of the HHS Agencies and on Capitol Hill.
- Because of WHG’s years of healthcare and government relations experience we understand how to acclimatize and manage the challenge of evolving political ideology and the potential impact on the healthcare delivery system.
Federal Regulations - CMS reimbursement processes, CDC guidance, FDA regulations and NIH expanded research
are not intuitive and can lead to uncertainties and market access complications especially during the HHS Emergency Use Authorization (EUA) Authority
are not intuitive and can lead to uncertainties and market access complications especially during the HHS Emergency Use Authorization (EUA) Authority